Font Size: a A A
Keyword [Macrovascular]
Result: 41 - 60 | Page: 3 of 9
41. The Relationship Of Plasma Homocysteine And Macrovascular Diseases In Type 2 Diabetics
42. Research Of The Relation Between MBL And Type 2 Diabetic Pations With Macrovascular Complications
43. Relationship Between Amyloid Beta Peptide 40 And Type 2 Diabetes With Macrovascular Complications
44. The Level Of Advanced Glycation End Products And Analysis Of The Macrovascular Disease Risk Factors In The Impaired Glucose Regulation Patients
45. Research Of The Relationship Among Interleukin-18, Homocysteine, High-sensitivity C-reactive Protein And Macrovascular Complication In Type 2 Diabetes
46. Serum Free Fatty Acid Alteration In Oral Glucose Tolerance Test Of Type 2 Diabetes And Macrovascular Complications
47. The Relationship Between Macrovascular Complications Of Type 2 Diabetes Mellitus And The Level Of Plasma Tetrahydrobiopterin
48. The Changes And Significance Of T Lymphocyte Subsets In Patients With Type 2 Diabetes With Or Without Macrovascular Complications
49. The Relationship Between Plasma Visfatin Level And Type 2 Diabetes Mellitus With Macrovascular Complications
50. The Association Of The PPAR Alpha Gene Polymorphism With Macroangiopathyin Type 2 Diabetes
51. Primary Prevention Of Macrovascular Diseases In Patients With Short-duration Type 2 Diabetes Mellitus By Intensified Multifactorial Intervention
52. The Effect Of Oxidative Stress And PECAM-1 On The Aorta Of Diabetic Rats And The Intervention Study Of Probucol
53. Serum Free Fatty Acid Profiles And Metabolism In Type 2 Diabetes Patients With Macrovascular Complications
54. The Role Of ADMA And Adiponectin In Macrovascular Disease Of Type 2 Diabetes
55. Study On The Relationship Between Visfatin, Tumor Necrosis Factor-α And Type 2 Diabetic Patients With Macrovascular Complications
56. The Role Of SET7/9 And LSD1 On Macrovascular Complications In Patients Wtih Type 2Diabetes
57. Experimental Study On The Effect Of Tongmai Jiangzhi Pill On Oxidative Stress In Diabetic Macrovascular Lesions
58. Diabetic Macrovascular Disease From Poisonous Evil
59. Diabetes Macrovascular Disease And Plasma High Sensitivity C-reactive Protein Relationship Between The Clinical Studies
60. Insulin Resistance And Macrovascular Disease
  <<First  <Prev  Next>  Last>>  Jump to